Overall, the current study showed that M3G activated TLR4 in NSCLC cells and upregulated PD-L1 expression through the PI3K signaling pathway, thereby inhibiting CTL cytotoxicity and finally promoting tumor escape from the immune system. The gene discussed is CD274; the disease is non-small cell lung carcinoma.